Home › Major Depressive Disorder › Utah
Major Depressive Disorder clinical trials in Utah
14 studies for Major Depressive Disorder are looking for participants at sites in Utah.
Cities in Utah
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Cedar Clinical Research, Draper
- Inner Space Research, Orem
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Nov 9, 2026 · NCT07592689ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Aura Wellness, Salt Lake City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 5, 2026 · NCT07284667A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07412756A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Boeson Research - Provo, Provo
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 3, 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Nov 3, 2026 · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Draper
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Provo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07621237Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Alpine Research Organization, Clinton
- Aura Wellness, Salt Lake City
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 28, 2026 · NCT07226661A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Draper
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07196501Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Utah Hospital, Salt Lake City
Recruiting
Ages 22 to 70 · All sexes · Updated Oct 16, 2026 · NCT064234305-HTP and Creatine for Depression R33 Phase
- University of Utah Department of Psychiatry, Salt Lake City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 27, 2026 · NCT05895747Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Andes Clinical Research, Orem
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Aug 3, 2026 · NCT06547489Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #159, Orem
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jan 20, 2026 · NCT06633016Mechanisms of Rumination Change in Adolescent Depression
- University of Utah, Salt Lake City
Recruiting
Ages 14 to 17 · All sexes · Updated Aug 11, 2025 · NCT03859297From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.